Hyloris Pharmaceuticals SA

EBR:HYL.BR

4.52 (EUR) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023202220212020201920182017
Operating Activities:
Net Income -15.38-10.77-11.579-7.145-5.274-5.469-3.866
Depreciation & Amortization 0.3480.1960.1370.5813.3060.0880.065
Deferred Income Tax -0.29400.1960.00100-1.329
Stock Based Compensation 0.540.560.5760.485001.329
Change In Working Capital 2.234-3.375-0.7770.031-2.5890.0130.856
Accounts Receivables 0.029-2.261-2.0680.0810.808-0.925-0.178
Inventory 0000000
Accounts Payables 1.05-0.4681.138-1.398-0.2180.9360.777
Other Working Capital 1.155-0.6460.1531.348-3.1790.0020.257
Other Non Cash Items 0.2330.2350.1971.477-0.0050.4851.329
Operating Cash Flow -12.182-13.154-11.25-4.57-4.562-5.368-1.616
Investing Activities:
Investments In Property Plant And Equipment -0.75-0.739-1.061-0.623-1.23-0.031-2.8
Acquisitions Net 00-1.27000.050.062
Purchases Of Investments 0-0.5-1.178-0.01000
Sales Maturities Of Investments 10.0010.5220.21600.00300.002
Other Investing Activites 0.001-11.7930.218-0.633-0.0010.05-2.736
Investing Cash Flow 9.251-1.239-3.075-0.633-1.2280.019-2.736
Financing Activities:
Debt Repayment 0000000
Common Stock Issued 017.169059.25405.750.012
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities -0.012-1.955018.2443.362.0584.407
Financing Cash Flow -0.1197.838-0.06269.3973.3087.7654.398
Other Information:
Effect Of Forex Changes On Cash -10.001000000.001
Net Change In Cash -3.051-6.555-14.38764.194-2.4822.4160.047
Cash At End Of Period 30.40643.45750.01264.3990.2052.6870.271